Selected research
Industry Research
Rosiglitazone Industry Research Report 2026
Market perspective
The global Rosiglitazone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Rosiglitazone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Rosiglitazone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Rosiglitazone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Rosiglitazone include Wanma Pharma, Taiji Group, Jingxin Pharma, Huanghe Pharma, Shengjitang Pharma, GSK, Hengrui Pharma and STADA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Rosiglitazone market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rosiglitazone Market by Company
Wanma Pharma
Taiji Group
Jingxin Pharma
Huanghe Pharma
Shengjitang Pharma
GSK
Hengrui Pharma
STADA
Rosiglitazone Segment by Type
Rosiglitazone Hydrochloride Tablets
Rosiglitazone Maleate Tablets
Rosiglitazone Tablets
Others
Rosiglitazone Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Rosiglitazone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosiglitazone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosiglitazone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosiglitazone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rosiglitazone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rosiglitazone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rosiglitazone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rosiglitazone Hydrochloride Tablets
- Rosiglitazone Maleate Tablets
- Rosiglitazone Tablets
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Wanma Pharma
- Taiji Group
- Jingxin Pharma
- Huanghe Pharma
- Shengjitang Pharma
- GSK
- Hengrui Pharma
- STADA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Rosiglitazone Market Size (2021-2032)
- 2.2.2 Global Rosiglitazone Sales (2021-2032)
- 2.2.3 Global Rosiglitazone Market Average Price (2021-2032)
- 2.3 Rosiglitazone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Rosiglitazone Hydrochloride Tablets
- 2.3.3 Rosiglitazone Maleate Tablets
- 2.3.4 Rosiglitazone Tablets
- 2.3.5 Others
- 2.4 Rosiglitazone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Rosiglitazone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Rosiglitazone Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Rosiglitazone Revenue of Manufacturers (2021-2026)
- 3.4 Global Rosiglitazone Average Price by Manufacturers (2021-2026)
- 3.5 Global Rosiglitazone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Rosiglitazone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Rosiglitazone, Product Type & Application
- 3.8 Global Manufacturers of Rosiglitazone, Established Date
- 3.9 Global Rosiglitazone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wanma Pharma
- 4.1.1 Wanma Pharma Company Information
- 4.1.2 Wanma Pharma Business Overview
- 4.1.3 Wanma Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wanma Pharma Rosiglitazone Product Portfolio
- 4.1.5 Wanma Pharma Recent Developments
- 4.2 Taiji Group
- 4.2.1 Taiji Group Company Information
- 4.2.2 Taiji Group Business Overview
- 4.2.3 Taiji Group Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Taiji Group Rosiglitazone Product Portfolio
- 4.2.5 Taiji Group Recent Developments
- 4.3 Jingxin Pharma
- 4.3.1 Jingxin Pharma Company Information
- 4.3.2 Jingxin Pharma Business Overview
- 4.3.3 Jingxin Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jingxin Pharma Rosiglitazone Product Portfolio
- 4.3.5 Jingxin Pharma Recent Developments
- 4.4 Huanghe Pharma
- 4.4.1 Huanghe Pharma Company Information
- 4.4.2 Huanghe Pharma Business Overview
- 4.4.3 Huanghe Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Huanghe Pharma Rosiglitazone Product Portfolio
- 4.4.5 Huanghe Pharma Recent Developments
- 4.5 Shengjitang Pharma
- 4.5.1 Shengjitang Pharma Company Information
- 4.5.2 Shengjitang Pharma Business Overview
- 4.5.3 Shengjitang Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shengjitang Pharma Rosiglitazone Product Portfolio
- 4.5.5 Shengjitang Pharma Recent Developments
- 4.6 GSK
- 4.6.1 GSK Company Information
- 4.6.2 GSK Business Overview
- 4.6.3 GSK Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GSK Rosiglitazone Product Portfolio
- 4.6.5 GSK Recent Developments
- 4.7 Hengrui Pharma
- 4.7.1 Hengrui Pharma Company Information
- 4.7.2 Hengrui Pharma Business Overview
- 4.7.3 Hengrui Pharma Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hengrui Pharma Rosiglitazone Product Portfolio
- 4.7.5 Hengrui Pharma Recent Developments
- 4.8 STADA
- 4.8.1 STADA Company Information
- 4.8.2 STADA Business Overview
- 4.8.3 STADA Rosiglitazone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 STADA Rosiglitazone Product Portfolio
- 4.8.5 STADA Recent Developments
5 Global Rosiglitazone Market Scenario by Region
- 5.1 Global Rosiglitazone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Rosiglitazone Sales by Region: 2021-2032
- 5.2.1 Global Rosiglitazone Sales by Region: 2021-2026
- 5.2.2 Global Rosiglitazone Sales by Region: 2027-2032
- 5.3 Global Rosiglitazone Revenue by Region: 2021-2032
- 5.3.1 Global Rosiglitazone Revenue by Region: 2021-2026
- 5.3.2 Global Rosiglitazone Revenue by Region: 2027-2032
- 5.4 North America Rosiglitazone Market Facts & Figures by Country
- 5.4.1 North America Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Rosiglitazone Sales by Country (2021-2032)
- 5.4.3 North America Rosiglitazone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Rosiglitazone Market Facts & Figures by Country
- 5.5.1 Europe Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Rosiglitazone Sales by Country (2021-2032)
- 5.5.3 Europe Rosiglitazone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Rosiglitazone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Rosiglitazone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Rosiglitazone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Rosiglitazone Market Facts & Figures by Country
- 5.7.1 South America Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Rosiglitazone Sales by Country (2021-2032)
- 5.7.3 South America Rosiglitazone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Rosiglitazone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Rosiglitazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Rosiglitazone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Rosiglitazone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Rosiglitazone Sales by Type (2021-2032)
- 6.1.1 Global Rosiglitazone Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Rosiglitazone Sales Market Share by Type (2021-2032)
- 6.2 Global Rosiglitazone Revenue by Type (2021-2032)
- 6.2.1 Global Rosiglitazone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Rosiglitazone Revenue Market Share by Type (2021-2032)
- 6.3 Global Rosiglitazone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Rosiglitazone Sales by Application (2021-2032)
- 7.1.1 Global Rosiglitazone Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Rosiglitazone Sales Market Share by Application (2021-2032)
- 7.2 Global Rosiglitazone Revenue by Application (2021-2032)
- 7.2.1 Global Rosiglitazone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Rosiglitazone Revenue Market Share by Application (2021-2032)
- 7.3 Global Rosiglitazone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Rosiglitazone Value Chain Analysis
- 8.1.1 Rosiglitazone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Rosiglitazone Production Mode & Process
- 8.2 Rosiglitazone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Rosiglitazone Distributors
- 8.2.3 Rosiglitazone Customers
9 Global Rosiglitazone Analyzing Market Dynamics
- 9.1 Rosiglitazone Industry Trends
- 9.2 Rosiglitazone Industry Drivers
- 9.3 Rosiglitazone Industry Opportunities and Challenges
- 9.4 Rosiglitazone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst